Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03385343 · ClinicalTrials.gov registry record · NA
Staging of Superficial EAC Using VLE
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03385343: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT03385343 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03385343, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study is being done to see if the NvisionVLE Imaging System can accurately determine the diagnostic performance of staging of T1 esophageal adenocarcinoma.
Interventions
- DIAGNOSTIC_TEST VLE imaging for staging EAC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-05-05 |
| Est. Completion | 2021-09-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03385343
The ClinicalTrials.gov registry entry for NCT03385343 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VLE imaging for staging EAC is the first listed.
NCT03385343 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03385343 about?
NCT03385343 is a clinical study titled "Staging of Superficial EAC Using VLE". This study is being done to see if the NvisionVLE Imaging System can accurately determine the diagnostic performance of staging of T1 esophageal adenocarcinoma.
What is the current status of trial NCT03385343?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2017-05-05. Estimated completion is 2021-09-08.
What interventions are being tested in trial NCT03385343?
The interventions under investigation include: VLE imaging for staging EAC (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03385343?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.